Clinical Trial

A Study of NWRD09 in Participants With Persistent HPV16 Infection in the Anal Region

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is an open-label, single-center, investigator-initiated exploratory trial evaluating NWRD09 in 10 participants with persistent HPV16 infection in the anal region.
Trial Details
NCT Number NCT07710664
Lead Sponsor Newish Biotech (Wuxi) Co., Ltd.
Conditions Persistent HPV16 Infection
Enrollment 10 participants
Start Date 2026-07-20
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-17